Toe Walking
No Results
No Results
processing….
Toe walking is a gait abnormality characterized by an absence of normal heel-to-floor contact (heel strike) by both feet during gait. It is defined as the inability to make heel contact with the floor during the initial stance phase of the gait cycle and the absence of full foot contact with the ground during the remainder of the gait cycle. The forefoot engages in the majority of floor contact throughout the gait cycle.
Toe walking has multiple etiologies, ranging from idiosyncratic habit to profound neuromuscular disease. The most commonly observed type of toe walking is idiopathic toe walking (ITW), which is a diagnosis of exclusion. Toe walking that results from a definable cause (most often neurologic or muscular disease) can be broadly labeled nonidiopathic toe walking (non-ITW). Identification of non-ITW is critical for determining appropriate treatment and understanding recurrence rates.
Although toe walking is commonly seen during development in children who are first learning to walk, a consistent heel-toe pattern of gait usually develops by approximately age 22 months. [1, 2] If toe walking persists beyond age 2 years, further evaluation is warranted. [3]
Treatment depends on the patient’s age, the severity of the gait abnormality, and the underlying diagnosis. Specific treatment options range from simple observation to surgical lengthening of muscles or tendons in the lower extremity. Achilles tendon tenotomy is the commonly used procedure for the treatment of toe walking and is one of the oldest procedures in orthopedics. [4]
For patient education resources, see Cast Care.
The triceps surae muscle-tendon complex is the confluence of the gastrocnemius and soleus muscles and the Achilles tendon or heel cord, the largest tendon in the human body.
The gastrocnemius muscle originates from the posterior medial and lateral femoral condyles and inserts onto the calcaneus through the Achilles tendon. It crosses both the knee and the ankle joints and acts as a major plantarflexor of the ankle and a minor flexor of the knee. It typically has more fast-twitch type II muscle fibers, which are responsible for short, powerful bursts of activity such as running and jumping.
The soleus muscle lies deep (anterior) to the gastrocnemius and originates from the posterior surfaces of the proximal tibia and fibula and inserts into the calcaneus by way of the conjoined Achilles tendon. It crosses only the ankle joint and functions to plantarflex the ankle. The soleus muscle is made up of primarily slow-twitch type I muscle fibers and is responsible primarily for postural control.
The Achilles tendon measures approximately 4-8 cm from the point where the gastrocnemius and soleus muscles join to its insertion on the calcaneus. As the fibers of the tendon traverse this distance, they rotate approximately 90º in the axial plane. The fibers from the more superficial gastrocnemius muscle insert on the posterolateral aspect of the calcaneus, and the fibers from the deeper soleus muscle insert on the posteromedial aspect of the calcaneus. [5] Understanding this rotation of the fibers helps in planning the percutaneous lengthening procedure (see Surgical Therapy).
It is possible to separate the contributions of the gastrocnemius and soleus muscles to an equinus ankle contracture via the Silfverskiöld test. According to this test, increased ankle dorsiflexion with the knee in flexion compared with the knee in extension indicates gastrocnemius tightness. This occurs because the gastrocnemius relaxes with knee flexion as the muscle spans the knee joint, whereas the soleus does not. If there is no difference in dorsiflexion with knee flexion, an Achilles tendon contracture is present. The test assists in deciding the surgical approach to lengthening of a patient’s heel cord.
Although the exact pathophysiology of ITW remains unknown, it is postulated that mild defects in sensory processing exist in affected children and that this gait may result from a vestibular disorder or abnormal sensitivity to touch. [6] However, there is limited research exploring these relations.
ITW likely has a genetic component, in that a positive family history has been reported in many case series. [7] In the initial description of the condition, Hall et al noted that all their patients had congenital shortness of the Achilles tendon, which led to ankle equinus and toe walking. [8] However, subsequent studies found that not all patients with ITW exhibit a congenitally short Achilles tendon as a mechanical explanation for the gait difference and that some patients toe-walk despite a volitional ability to walk flatfooted (“dynamic” or “habitual” toe walkers). [7]
Causes of non-ITW may be broadly separated into neurologic and muscular etiologies, classic examples of which are cerebral palsy (CP) and Duchenne muscular dystrophy (DMD), respectively. In patients with CP, the pathophysiology of toe walking is clearer and is thought to be a product of two basic mechanisms resulting from lower-extremity muscle spasticity, as follows [9] :
In DMD, lower-extremity muscles progressively weaken as they degenerate and are replaced by fibrous tissue. Toe walking results from the relatively greater weakening of the dorsiflexors of the foot as compared with the plantarflexors. Toe walking also develops to compensate for the weakening quadriceps muscle. As the quadriceps weakens, active knee extension is lost, and the knee preferentially buckles into flexion with each step. By walking on the forefoot, the patient generates a knee-extension moment that aids in providing knee stability. [10]
The etiology of toe walking is broadly separated into two categories, ITW causes and non-ITW causes. Non-ITW causes include both central and peripheral neurologic disorders (eg, tethered cord, diastematomyelia, spina bifida, and cerebral palsy), muscular disorders (eg, congenital muscular dystrophy), and anatomic disorders (eg, limb-length discrepancy). [3] Some rarer causes of toe walking have also been reported in the literature, such as acute toe walking secondary to viral myositis in a previously healthy 4-year-old child. [11]
ITW is the most common form of toe walking (with the term idiopathic understood to mean that no identifiable pathologic process exists to explain the perceived gait abnormality). ITW, first described by Hall in 1967 as “habitual toe walking” and “congenital short Achilles tendon,” is a diagnosis of exclusion. [8] It is best defined as bilateral toe walking with or without Achilles tendon contracture in a child older than age 2 years in the absence of other identifiable causes. (See Physical Medicine and Rehabilitation for Spasticity, Spinal Cord Trauma and Related Diseases, Muscular Dystrophy, and Congenital Myopathies.)
The true prevalence of ITW is unknown because not all children with this condition present to a physician.
In several small studies, ITW was estimated to occur in 7-24% of the childhood population. [12] A large Dutch cross-sectional study from 2011 found a prevalence of 12% in the general population. [12] A large Swedish study from 2012 found the prevalence of ITW to be 4.9% in children aged 5 years 6 months. [13] A comprehensive literature review published by Ruzbarsky et al in 2016 found the prevalence at 5.5 years to be 2% in normally developing children and 41% in children with a neuropsychiatric diagnosis or developmental delay. [14]
ITW is observed more frequently in patients with autism, developmental delay, and language disorders. [7] A 2011 study determined the incidence of toe walking in children with autistic spectrum disorder to be 20.1%, whereas historical reports estimated it to be as high as 63%. [15] Conversely, children with ITW display an increased prevalence for other pediatric neuropsychiatric disorders, such as attention-deficit/hyperactivity disorder, tics, Tourette syndrome, and obsessive-compulsive disorder. [16]
A 2016 article by Baber et al reviewed the birth characteristics of children with ITW or toe walking due to medical reasons. [17] They evaluated 95 children diagnosed with ITW (mean age, 5.8 ± 2.9 years). These children were found to have higher rates of prematurity, higher rates of admission to a special care nursery or neonatal intensive care unit, and lower birth weights than the normative population. Children with a medical reason for toe walking also had greater rates of prematurity than the normative population and more instrumented births than children with ITW.
Baber et al found no association between assisted-birth intervention and the ITW cohort in comparison with the normative population or the medical-cause cohort. [17] ITW gait was associated with higher rates of complications during and after delivery. Such complications have previously been cited as risk factors for neurologic insult affecting motor development.
The most common cause of non-ITW is CP, which affects 1-7 in 1000 children. Reports vary greatly regarding the incidence of toe walking in this population, largely because of the wide spectrum of disease severity. Generally, fewer than 50% of these patients walk on their toes. [18]
DMD is the most common primary muscle-disease etiology of non-ITW. It has an incidence of 1 case per 3500 live male births and is the most common degenerative muscle disease of childhood. [19] The typical child with DMD initially walks with a heel-to-toe pattern but progresses to a consistent toe-walking pattern as a product of Achilles tendon contracture and a compensation for knee extensors.
The natural history of ITW remains poorly defined. Most studies offering long-term follow-up for untreated patients concurrently report treatment of their cohorts. Opinion on the adult consequences of a persistent toe-walking pattern are generally divided into two schools of thought.
The first school of thought holds that regardless of the initial status of the heel cord and ankle range of motion (ROM), children with persistent toe walking eventually develop a fixed ankle contracture and ankle equinus in adulthood, which lead to hindfoot valgus and myriad potential foot disorders. [20, 21, 22, 23, 24] This argument supports aggressive intervention for ITW in early childhood.
The second school of thought holds that ITW can have a benign natural history, with the majority of patients manifesting no particular functional limitations or pathologic sequelae in adulthood, despite variable objective improvement in overall ankle ROM or gait. [25] This argument supports an observational approach to management of this gait abnormality.
The long-term results of treatment for ITW are unclear, mostly because of an unclear comparative natural history but also because of a tendency of the studies to mix a variety of management methods.
Reported outcomes of treatment of ITW with stretching casts have been variable. In a long-term study of 14 children with ITW treated with a stretching regimen with or without casting, only three children required additional treatment for persistent toe walking after several years. [26] However, in a larger series, no difference in outcome was seen between patients treated with observation and those treated with serial casting: 50% of both groups had improvements in gait. [25] Other studies showed similar variability, with one finding 66% of patients to have improved ankle dorsiflexion and gait after casting. [25, 27, 28]
Overall, casting management seems to be most successful in patients with an initial ankle dorsiflexion of greater than 0º. In addition, recurrence of toe walking is unlikely in patients who have spontaneously discontinued toe walking or who remain down on their heels for more than 1 year after casting treatment. [3]
Surgical management of ITW, through either complete Achilles lengthening or isolated gastrocnemius lengthening, appears to be effective in the appropriate clinical setting. [29] In one study, 72% of surgically treated patients reported a normal or improved gait at follow-up. [25] In another, all surgically treated patients showed improvement in ankle dorsiflexion, and the reported parental satisfaction rate was 67%. [28] Long-term outcome studies suggest that surgical management is more effective than nonsurgical management. However, direct comparison is difficult, owing to the variability of patient age and disease severity in these studies. [25]
The natural history for patients with non-ITW from spasticity or paralytic muscle disease is generally thought to be one of persisting ambulatory instability, given the poor balance mechanics afforded by the overriding disease process coupled with the poor base of support from the foot position. Intervention is more often recommended for this patient population for the purpose of improving gait stability. However, interventions for toe walking are also less predictable in this population, and patients often require long-term follow-up to monitor for recurrence. [30]
In patients with CP, treatment of ambulatory individuals without a fixed ankle contracture by means of full-time bracing (ankle-foot orthoses [AFOs]) has been shown to have a positive effect on ankle ROM and power at pushoff. [31] Among CP patients who have a rigid deformity, children younger than 7 years at the time of surgery have been shown to be at greater risk for recurrence. Hemiplegic patients have also been found to have higher recurrence rates than diplegic patients. [32]
However, surgical lengthening can have lasting results. In one long-term study, surgical lengthening in CP patients with a fixed equinus contracture resulted in a significant gain in average dorsiflexion, from –25° preoperatively to 8° postoperatively, and this correction was maintained by stretching and AFOs in 80% of patients 7 years after the index procedure. [33]
Randomized controlled studies have not shown botulinum toxin alone to offer better long-term outcomes than casting alone for dynamic equinus in children with CP or ITW. [34, 35] Furthermore, combining botulinum toxin injections with casting has not been shown to yield improved results as compared with casting alone for either toe-walking CP patients or patients with ITW. [34, 35]
Caselli MA, Rzonca EC, Lue BY. Habitual toe-walking: evaluation and approach to treatment. Clin Podiatr Med Surg. 1988 Jul. 5(3):547-59. [Medline].
Sutherland DH, Olshen R, Cooper L, Woo SL. The development of mature gait. J Bone Joint Surg Am. 1980 Apr. 62(3):336-53. [Medline].
Pernet J, Billiaux A, Auvin S, Rakatovao D, Morin L, Presedo A. Early onset toe-walking in toddlers: a cause for concern?. J Pediatr. 2010 Sep. 157(3):496-8. [Medline].
Dobbs MB, Morcuende JA, Gurnett CA, Ponseti IV. Treatment of idiopathic clubfoot: an historical review. Iowa Orthop J. 2000. 20:59-64. [Medline]. [Full Text].
Doral MN, Alam M, Bozkurt M, Turhan E, Atay OA, Dönmez G, et al. Functional anatomy of the Achilles tendon. Knee Surg Sports Traumatol Arthrosc. 2010 May. 18(5):638-43. [Medline].
Williams CM, Tinley P, Curtin M, Wakefield S, Nielsen S. Is idiopathic toe walking really idiopathic? The motor skills and sensory processing abilities associated with idiopathic toe walking gait. J Child Neurol. 2014 Jan. 29(1):71-8. [Medline].
Oetgen ME, Peden S. Idiopathic toe walking. J Am Acad Orthop Surg. 2012 May. 20(5):292-300. [Medline].
Hall JE, Salter RB, Bhalla SK. Congenital short tendo calcaneus. J Bone Joint Surg Br. 1967 Nov. 49(4):695-7. [Medline].
Green NE. The orthopaedic management of the ankle, foot, and knee in patients with cerebral palsy. Instr Course Lect. 1987. 36:253-65. [Medline].
Williams EA, Read L, Ellis A, Morris P, Galasko CS. The management of equinus deformity in Duchenne muscular dystrophy. J Bone Joint Surg Br. 1984 Aug. 66(4):546-50. [Medline].
McAbee GN. Acute toe walking with viral myositis. Pediatr Neurol. 2013 Nov. 49(5):e11. [Medline].
Engelbert R, Gorter JW, Uiterwaal C, van de Putte E, Helders P. Idiopathic toe-walking in children, adolescents and young adults: a matter of local or generalised stiffness?. BMC Musculoskelet Disord. 2011 Mar 21. 12:61. [Medline]. [Full Text].
Engström P, Tedroff K. The prevalence and course of idiopathic toe-walking in 5-year-old children. Pediatrics. 2012 Aug. 130(2):279-84. [Medline].
Ruzbarsky JJ, Scher D, Dodwell E. Toe walking: causes, epidemiology, assessment, and treatment. Curr Opin Pediatr. 2016 Feb. 28 (1):40-6. [Medline].
Barrow WJ, Jaworski M, Accardo PJ. Persistent toe walking in autism. J Child Neurol. 2011 May. 26(5):619-21. [Medline].
Engström P, Van’t Hooft I, Tedroff K. Neuropsychiatric symptoms and problems among children with idiopathic toe-walking. J Pediatr Orthop. 2012 Dec. 32(8):848-52. [Medline].
Baber S, Michalitsis J, Fahey M, Rawicki B, Haines T, Williams C. A Comparison of the Birth Characteristics of Idiopathic Toe Walking and Toe Walking Gait Due to Medical Reasons. J Pediatr. 2016 Apr. 171:290-3. [Medline].
Oskoui M, Coutinho F, Dykeman J, Jetté N, Pringsheim T. An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Dev Med Child Neurol. 2013 Jun. 55(6):509-19. [Medline].
Rodino-Klapac LR, Mendell JR, Sahenk Z. Update on the treatment of Duchenne muscular dystrophy. Curr Neurol Neurosci Rep. 2013 Mar. 13(3):332. [Medline].
Sobel E, Caselli MA, Velez Z. Effect of persistent toe walking on ankle equinus. Analysis of 60 idiopathic toe walkers. J Am Podiatr Med Assoc. 1997 Jan. 87(1):17-22. [Medline].
Neptune RR, Burnfield JM, Mulroy SJ. The neuromuscular demands of toe walking: a forward dynamics simulation analysis. J Biomech. 2007. 40(6):1293-300. [Medline].
Sasaki K, Neptune RR, Burnfield JM, Mulroy SJ. Muscle compensatory mechanisms during able-bodied toe walking. Gait Posture. 2008 Apr. 27(3):440-6. [Medline].
Westberry DE, Davids JR, Davis RB, de Morais Filho MC. Idiopathic toe walking: a kinematic and kinetic profile. J Pediatr Orthop. 2008 Apr-May. 28(3):352-8. [Medline].
Solan MC, Kohls-Gatzoulis J, Stephens MM. Idiopathic toe walking and contractures of the triceps surae. Foot Ankle Clin. 2010 Jun. 15(2):297-307. [Medline].
Eastwood DM, Menelaus MB, Dickens DR, Broughton NS, Cole WG. Idiopathic toe-walking: does treatment alter the natural history?. J Pediatr Orthop B. 2000 Jan. 9(1):47-9. [Medline].
Hirsch G, Wagner B. The natural history of idiopathic toe-walking: a long-term follow-up of fourteen conservatively treated children. Acta Paediatr. 2004 Feb. 93(2):196-9. [Medline].
Fox A, Deakin S, Pettigrew G, Paton R. Serial casting in the treatment of idiopathic toe-walkers and review of the literature. Acta Orthop Belg. 2006 Dec. 72(6):722-30. [Medline].
Stricker SJ, Angulo JC. Idiopathic toe walking: a comparison of treatment methods. J Pediatr Orthop. 1998 May-Jun. 18(3):289-93. [Medline].
McMulkin ML, Baird GO, Caskey PM, Ferguson RL. Comprehensive outcomes of surgically treated idiopathic toe walkers. J Pediatr Orthop. 2006 Sep-Oct. 26(5):606-11. [Medline].
Rattey TE, Leahey L, Hyndman J, Brown DC, Gross M. Recurrence after Achilles tendon lengthening in cerebral palsy. J Pediatr Orthop. 1993 Mar-Apr. 13(2):184-7. [Medline].
Kranzl A, Grasl C, Csepan R, Grill F. Outcome of 23h Bracing for Tip-toe-walking Children with Cerebral Palsy. Biomed Tech (Berl). 2013 Aug. 58 Suppl 1:[Medline].
Koman LA, Smith BP, Barron R. Recurrence of equinus foot deformity in cerebral palsy patients following surgery: a review. J South Orthop Assoc. 2003. 12(3):125-33, quiz 134. [Medline].
Damron TA, Greenwald TA, Breed AL. Chronologic outcome of surgical tendoachilles lengthening and natural history of gastroc-soleus contracture in cerebral palsy. A two-part study. Clin Orthop Relat Res. 1994 Apr. (301):249-55. [Medline].
Engström P, Bartonek Å, Tedroff K, Orefelt C, Haglund-Åkerlind Y, Gutierrez-Farewik EM. Botulinum toxin A does not improve the results of cast treatment for idiopathic toe-walking: a randomized controlled trial. J Bone Joint Surg Am. 2013 Mar 6. 95(5):400-7. [Medline].
Ackman JD, Russman BS, Thomas SS, Buckon CE, Sussman MD, Masso P. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy. Dev Med Child Neurol. 2005 Sep. 47(9):620-7. [Medline].
Pomarino D, Ramírez Llamas J, Pomarino A. Idiopathic Toe Walking: Tests and Family Predisposition. Foot Ankle Spec. 2016 Aug. 9 (4):301-6. [Medline].
Kalen V, Adler N, Bleck EE. Electromyography of idiopathic toe walking. J Pediatr Orthop. 1986 Jan-Feb. 6(1):31-3. [Medline].
Policy JF, Torburn L, Rinsky LA, Rose J. Electromyographic test to differentiate mild diplegic cerebral palsy and idiopathic toe-walking. J Pediatr Orthop. 2001 Nov-Dec. 21(6):784-9. [Medline].
Rose J, Martin JG, Torburn L, Rinsky LA, Gamble JG. Electromyographic differentiation of diplegic cerebral palsy from idiopathic toe walking: involuntary coactivation of the quadriceps and gastrocnemius. J Pediatr Orthop. 1999 Sep-Oct. 19(5):677-82. [Medline].
Hicks R, Durinick N, Gage JR. Differentiation of idiopathic toe-walking and cerebral palsy. J Pediatr Orthop. 1988 Mar-Apr. 8(2):160-3. [Medline].
Kelly IP, Jenkinson A, Stephens M, O’Brien T. The kinematic patterns of toe-walkers. J Pediatr Orthop. 1997 Jul-Aug. 17(4):478-80. [Medline].
O’Sullivan R, O’Brien T. Idiopathic Toe Walking: A Gait Laboratory Review. Ir Med J. 2015 Jul-Aug. 108 (7):214-6. [Medline].
Williams CM, Tinley P, Curtin M. The Toe Walking Tool: a novel method for assessing idiopathic toe walking children. Gait Posture. 2010 Oct. 32(4):508-11. [Medline].
Pu F, Fan X, Yang Y, Chen W, Li S, Li D. Feedback system based on plantar pressure for monitoring toe-walking strides in children with cerebral palsy. Am J Phys Med Rehabil. 2014 Feb. 93(2):122-9. [Medline].
Williams CM, Michalitsis J, Murphy AT, Rawicki B, Haines TP. Whole-Body Vibration Results in Short-Term Improvement in the Gait of Children With Idiopathic Toe Walking. J Child Neurol. 2016 Aug. 31 (9):1143-9. [Medline].
Koman LA, Mooney JF 3rd, Smith B, Goodman A, Mulvaney T. Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop. 1993 Jul-Aug. 13(4):489-95. [Medline].
van Kuijk AA, Kosters R, Vugts M, Geurts AC. Treatment for idiopathic toe walking: a systematic review of the literature. J Rehabil Med. 2014 Nov. 46 (10):945-57. [Medline].
Hemo Y, Macdessi SJ, Pierce RA, Aiona MD, Sussman MD. Outcome of patients after Achilles tendon lengthening for treatment of idiopathic toe walking. J Pediatr Orthop. 2006 May-Jun. 26(3):336-40. [Medline].
Ryan Krochak, MD Orthopedic Sports Medicine and Cartilage Repair, Orlin and Cohen Orthopedics/Northwell Health
Ryan Krochak, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Orthopaedic Society for Sports Medicine, Arthroscopy Association of North America
Disclosure: Nothing to disclose.
August Funk, MD Resident Physician, Department of Orthopedic Surgery, Maimonides Medical Center
August Funk, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, International Congress for Joint Reconstruction, North American Spine Society
Disclosure: Nothing to disclose.
Mark C Lee, MD Assistant Professor, Department of Orthopedics, Connecticut Children’s Medical Center
Mark C Lee, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, Connecticut State Medical Society, Scoliosis Research Society, Pediatric Orthopaedic Society of North America, Connecticut Orthopaedic Society
Disclosure: Received honoraria from Synthes-Depuy for speaking and teaching.
Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference
Disclosure: Received salary from Medscape for employment. for: Medscape.
Vinod K Panchbhavi, MD, FACS Professor of Orthopedic Surgery, Chief, Division of Foot and Ankle Surgery, Director, Foot and Ankle Fellowship Program, Department of Orthopedics, University of Texas Medical Branch School of Medicine
Vinod K Panchbhavi, MD, FACS is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American College of Surgeons, American Orthopaedic Association, American Orthopaedic Foot and Ankle Society, Orthopaedic Trauma Association, Texas Orthopaedic Association
Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: Styker.
John S Early, MD Foot/Ankle Specialist, Texas Orthopaedic Associates, LLP; Co-Director, North Texas Foot and Ankle Fellowship, Baylor University Medical Center
John S Early, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Medical Association, American Orthopaedic Foot and Ankle Society, Orthopaedic Trauma Association, Texas Medical Association
Disclosure: Received honoraria from AO North America for speaking and teaching; Received consulting fee from Stryker for consulting; Received consulting fee from Biomet for consulting; Received grant/research funds from AO North America for fellowship funding; Received honoraria from MMI inc for speaking and teaching; Received consulting fee from Osteomed for consulting; Received ownership interest from MedHab Inc for management position.
Edwards P Schwentker, MD Professor, Departments of Orthopedics and Rehabilitation and Pediatrics, Pennsylvania State College of Medicine
Disclosure: Nothing to disclose.
Toe Walking
Research & References of Toe Walking|A&C Accounting And Tax Services
Source
0 Comments